TP53 and colorectal carcinoma: Also, tumor suppressor miRNAs and oncomiRs supported their roles in CRC stem cells, epithelial-to-mesenchymal transition via different signalling pathways such as the Wnt/β-catenin activation, epidermal growth factor receptor (EGFR) pathway (transforming growth factor-beta {TGF-ß}), and the TP53 network [35].